Nuclear Medicine & Radiation Therapy

Aruna Turaka

Aruna Turaka
Physician, Radiation Oncology, Wendt Cancer center
USA

Biography

Faculty Appointments 2011- Assistant professor, Fox Chase Cancer Center, 2009- 2011Clinical Instructor, Fox Chase Cancer Center 2008 - 2009Fellow, Radiation Oncology, Fox Chase Cancer Center2006 – 2007 Oncologist’s Associate, Department of Radiation Oncology, Metro hospitals & Cancer Institute, New Delhi, India. 2005 - 2006Research Officer, Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India. 2002 - 2005Senior Resident, Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India , 1999 - 2002Resident in Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India, 1996 – 1997 Internship, Government General Hospital, Guntur, Andhra Pradesh, India 1992 - 1996M.B.B.S, Guntur Medical College, Guntur, Andhra Pradesh, India
 

Research Interest

Aruna Turaka′s research interests are: Lung cancer involving the stereotactic body radiation therapy both for the primary and metastatic disease along with the role of different radiation therapy techniques for the resectable and unresectable NSCLC. Also, she is part of the clinical trials involving the use of targeted agents in the treatment of LANSCLC with concurrent chemoradiation therapy at Fox Chase Cancer Center. She has developed a database of the treatment of Head and neck malignancies with IMRT at FCCC during her fellowship, presented data at several national meetings and published in peer/non-peer reviewed journals.  she has also developed a database on ocular lymphoma and extra-nodal lymphoma and published/presented her work at different meetings. As a junior faculty at FCCC, she developed a database on the treatment outcomes for the Merkel Cell Carcinoma and presented abstracts in collaboration with the multispeciality teams at FCCC. Presently, she is developing a database on the SBRT outcomes for both the primary and metastatic lung cancer.  she has been given merit awards at national meetings for the H&N, Lymphoma presentations.